Evaluating Workiva (WK) After Recent Share Weakness And A 29.7% Undervaluation Signal

Advertisement

Workiva stock: event-driven snapshot

Workiva (WK) has drawn investor attention after a period of weaker share performance, with the stock down about 12% over the past month and roughly 23% over the past year.

See our latest analysis for Workiva.

The recent 1 day share price return of 6.18% decline, together with a 30 day share price return of 11.6% decline and a 1 year total shareholder return of 23% loss, suggests momentum has been fading as investors reassess growth prospects and risk.

If you are comparing Workiva with other software names, this could be a good moment to see what else is moving across tech and AI by screening for high growth tech and AI stocks.

So with Workiva trading at a discount to some analyst targets and an indicated intrinsic discount, yet still posting revenue growth alongside a net loss, are you looking at an undervalued growth story or a stock where future gains are already priced in?

Most Popular Narrative: 29.7% Undervalued

With Workiva last closing at $76.27 against a narrative fair value of about $108.45, the current setup leans heavily on future execution and earnings power.

The analysts are assuming Workiva's revenue will grow by 20.6% annually over the next 3 years. Analysts assume that profit margins will increase from 8.3% loss today to 2.7% profit in 3 years time.

Read the complete narrative.

Want to see what turns today’s loss into future profit in this narrative? Revenue gains, margin shifts and a rich earnings multiple all have roles to play.

Result: Fair Value of $108.45 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you still need to weigh the chance that changing regulations or weaker partner execution on deployments could hit growth and margins harder than this narrative assumes.

Find out about the key risks to this Workiva narrative.

Another Angle: What The P/S Ratio Is Saying

While the narrative and fair value work suggest upside, the current P/S of 5.1x paints a different picture. It sits above the US Software industry at 4.5x and above peers at 3.5x, yet it remains below a fair ratio estimate of 5.9x. Is that extra premium a source of comfort or a cause for concern for you?

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:WK P/S Ratio as at Jan 2026
NYSE:WK P/S Ratio as at Jan 2026

Build Your Own Workiva Narrative

If you look at this and think the story should read differently, or you simply want to test your own view against the data, you can build a custom thesis in just a few minutes with Do it your way.

A great starting point for your Workiva research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Ready for more investment ideas?

If you stop with just one company, you could miss opportunities that better fit your goals, so widen your view and pressure test your thinking with curated stock ideas.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Workiva might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:WK

Workiva

Provides cloud-based reporting solutions in the United States and internationally.

Undervalued with high growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1156.7% undervalued
53 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4852.5% undervalued
205 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43043.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9954.8% undervalued
14 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.7% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$539.0% undervalued
1 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.916.3% undervalued
89 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.6% undervalued
200 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.3% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0